Rizhsky raion, selo Garkalne, undefined

Marita Y Selga


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 832,812 
Other
 patents

Years Active: 1984

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marita Y Selga: Innovator in Cardiovascular Treatments

Introduction

Marita Y Selga is a notable inventor based in Rizhsky raion, selo Garkalne, SU. She has made significant contributions to the field of cardiovascular medicine through her innovative research and development of pharmaceutical compounds. Her work focuses on creating effective treatments with minimal side effects.

Latest Patents

Marita holds a patent for a compound known as 2,6-Dimethyl-3,5-dicarbomethoxy-4-(o-difluoromethylthiophenyl)-1,4-dihydropyridine. This compound exhibits pronounced hypotensive activity of prolonged duration and is capable of producing a coronarodilating effect. It is characterized by low toxicity, making it a promising candidate for treating various diseases of the cardiovascular system.

Career Highlights

Throughout her career, Marita has demonstrated a commitment to advancing medical science. Her innovative approach to drug development has led to breakthroughs that enhance patient care and treatment outcomes. She is recognized for her dedication to research and her ability to translate complex scientific concepts into practical applications.

Collaborations

Marita has collaborated with esteemed colleagues, including Valeria V Kastron and Rasma O Vitolin. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work in the field.

Conclusion

Marita Y Selga's contributions to cardiovascular medicine through her innovative patent highlight her role as a leading inventor in the field. Her work not only advances medical knowledge but also has the potential to improve the lives of many patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…